The 2010 Canadian Hypertension Education Program (CHEP) Recommendations: Guidelines for Pharmacists

Campbell NRC Kaczorowski J Lewanczuk RZ 2010 Canadian Hypertension Education Program (CHEP) recommendations: The scientific summary — an update of the 2010 theme and the science behind new CHEP recommendations. Can J Cardiol 2010;26(5):236–40.

Quinn RR Hemmelgarn BR Padwal RS The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 — blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2010;26(5):241–8.

Hackam DG Khan NA Hemmelgarn BR The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 — therapy. Can J Cardiol 2010;26(5):249–58.

Jamerson K Weber MA Bakris GL Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417–28.

Public Health Agency of Canada. Report from the Canadian Chronic Disease Surveillance System: Hypertension in Canada, 2010. Available: www.phac-aspc.gc.ca/cd-mc/cvd-mcv/ccdss-snsmc-2010/index-eng.php (accessed Sept. 28, 2010).

Wilkins K Campbell NRC Joffres MR Blood pressure in Canadian adults. Health Reports 2010;21(1).

Machado M Bajcar J Guzzo GC Einarson TR . Sensitivity of patient outcomes to pharmacist intervention. Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007;41:1770–81.

McLean DL McAlister FA Johnson JA A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: Study of Cardiovascular Risk Intervention by Pharmacists–Hypertension (SCRIP-HTN). Arch Intern Med 2008;168:2355–61.

Carter BL Ardery G Dawson JD Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009;169:1996–2002.

Carter BL Rogers M Daly J The potency of team-based care interventions for hypertension: A meta-analysis. Arch Intern Med 2009;169:1748–55.